See also this year's filing and all EDGAR filings for this company.
PDF Report 0001599298_2023_Summit_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001599298, Summit Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 656,712,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,798,000 |
| 2 | PropertyPlantAndEquipmentNet | 906,000 |
| 3 | remainder_Assets | 4,752,000 |
| 4 | LiabilitiesCurrent | 38,782,000 |
| 5 | LiabilitiesNoncurrent | 4,192,000 |
| 6 | remainder_Liabilities | 494,540,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 26,743,000 |
| 9 | ResearchAndDevelopmentExpense | 51,999,000 |
| 10 | remainder_Expenses | 8,468,000 |
| 11 | remainder_Revenues | 15,121,000 |
| 12 | remainder_NetIncome | -6,693,000 |
| 13 | remainder_ComprehensiveNetIncome | 304,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 664,168,000 |
| 1 | Liabilities | 537,514,000 |
| 2 | Expenses | 87,210,000 |
| 3 | Revenues | 15,121,000 |
| 4 | StockholdersEquity | 126,654,000 |
| 5 | NetIncome | -78,782,000 |
| 6 | ComprehensiveNetIncome | -78,630,000 |
| 7 | BaseVar | 655,505,000 |
| 8 | EconomicCapitalRatio | 0.232 |
Edgar->Model Mapping
Feature Distribution
Change over Time
